U.S. Logistics Stock News

Verizon Communications Inc. ( NYSE:VZ ) shares have had a really impressive month, gaining 26% after a shaky period...

In February 2026, Atomera Incorporated reported fourth-quarter 2025 sales of US$50,000 with a net loss of US$4.43 million, and full-year 2025 sales of US$65,000 with a net loss of US$20.17 million, alongside updated Delaware law-aligned bylaws. Alongside these results, Atomera highlighted progress integrating its MST technology into advanced Gate-All-Around transistor structures and GaN-on-silicon applications, supported by a new major equipment OEM partnership and collaborations with...

Some Renasant Corporation ( NYSE:RNST ) shareholders may be a little concerned to see that insider Milton Cole recently...

Atara Biotherapeutics, Inc.'s ( NASDAQ:ATRA ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a strong...

Anyone interested in Aehr Test Systems, Inc. ( NASDAQ:AEHR ) should probably be aware that the Founder & Independent...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

Agnico Eagle Mines Limited ( NYSE:AEM ) has announced that it will be increasing its dividend from last year's...

Eversource Energy ( NYSE:ES ) will increase its dividend from last year's comparable payment on the 31st of March to...

The board of Vishay Intertechnology, Inc. ( NYSE:VSH ) has announced that it will pay a dividend on the 26th of March...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

We wouldn't blame Fifth Third Bancorp ( NASDAQ:FITB ) shareholders if they were a little worried about the fact that...

It's not a stretch to say that Fuel Tech, Inc.'s ( NASDAQ:FTEK ) price-to-sales (or "P/S") ratio of 1.6x right now...

Community Financial System (CBU) has been drawing more attention recently as its share price and fundamentals give investors fresh data to weigh. The stock’s recent performance and current valuation metrics are now under closer review. See our latest analysis for Community Financial System. That recent move to a share price of $66.34 comes after a 7.38% 1 month share price return and a stronger 23.61% 3 month share price return. The 1 year total shareholder return of 5.30% points to more...

Earlier this week, Barclays upgraded Gossamer Bio to a “Strong Buy” rating, as institutional ownership climbed above 81% and attention centered on its lead investigational drug seralutinib for pulmonary arterial hypertension and related conditions. This combination of a stronger Wall Street stance and concentrated institutional exposure highlights how closely investors are watching seralutinib’s clinical and commercial potential. Against this backdrop, we’ll explore how Barclays’ upgrade and...

If you are wondering whether Array Digital Infrastructure is still fairly priced after its recent run, or if the market is already ahead of itself, this article is for you. The share price recently closed at US$50.88, with returns of 3.9% over 7 days, a 12.0% decline over 30 days, a 5.8% decline year to date, and a 30.1% return over 1 year. Recent news coverage has focused on Array Digital Infrastructure as part of broader discussions about digital infrastructure and telecom related stocks,...

If you are wondering whether Bancorp's current share price reflects its true worth, this article is going to focus squarely on what the numbers say about value. The stock last closed at US$58.57, after a 5.6% decline over the past week, a 15.9% decline over the last month, a 13.4% decline year to date, but a 57.6% return over three years and a 186.4% return over five years. Recent moves in the share price sit against a backdrop of ongoing attention on regional banks, including Bancorp, as...

Wondering if Virtu Financial at around US$38.34 is offering genuine value or if the easy money has already been made? This article walks through what the current price really implies. The stock has been relatively steady over the last week with a 0.5% decline. The return over 30 days is 3.9%, year to date is 17.6%, 1 year is 6.9%, and the 3 year and 5 year returns sit at 112.4% and 65.4% respectively. Recent attention on Virtu Financial has focused on its role as a major market maker and...

Revolve Group (NYSE:RVLV) has opened a flagship store at The Grove in Los Angeles. The new location brings the REVOLVE and FWRD brands into a single, high profile physical space. This marks an expansion of the company’s offline footprint beyond its core online model. Revolve Group is stepping further into brick and mortar with a flagship store at The Grove, a move that puts its online native brands in front of heavy foot traffic. The stock closed at $25.09, with returns over the past year...

In recent weeks, Cavco Industries announced that its CEO bought 1,000 shares for about US$495,000 while the company repurchased roughly US$44,000,000 of its stock, following a post-earnings pullback earlier this year. This combination of insider buying and corporate buybacks has been interpreted by many investors as a clear signal of management’s conviction in the business. We’ll now examine how this renewed insider confidence, highlighted by the CEO’s recent purchase, may influence Cavco’s...

If you are wondering whether Upbound Group’s current share price still offers value, this article will walk through the numbers in a clear, practical way. The stock last closed at US$20.31, with a 17.1% gain year to date, following a 26.0% decline over the past year and a 50.2% decline over five years. Recent headlines around Upbound Group have focused on its position in the US retail space and how its business model fits within broader consumer spending trends. This backdrop helps explain...

Wendy's (WEN) closed FY 2025 with Q4 revenue of US$543 million and basic EPS of US$0.14, supported by trailing twelve month revenue of about US$2.2 billion and EPS of US$0.85 that frame the latest quarter in a softer earnings backdrop. Over recent periods, revenue has moved from US$574 million and EPS of US$0.23 in Q4 2024 to US$543 million and EPS of US$0.14 in Q4 2025. Trailing twelve month EPS shifted from US$0.95 at Q4 2024 to US$0.85 at Q4 2025, setting a more cautious tone around...

WEX (WEX) has just wrapped up FY 2025 with Q4 revenue of US$672.9 million and basic EPS of US$2.45, while full year trailing twelve month revenue came in at about US$2.7 billion and EPS at US$8.57. Over recent quarters the company has seen revenue move from US$636.5 million in Q4 2024 to US$672.9 million in Q4 2025, with basic EPS shifting from US$1.62 to US$2.45 over the same period, giving investors a clear view of how the top and bottom lines have tracked into this latest print. With a...

Pulmovant, a Roivant Sciences company, has completed patient enrollment in the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. Enrollment finished ahead of schedule, marking a key clinical milestone for this potential first in class inhaled therapy. For investors watching Roivant Sciences (NasdaqGS:ROIV), this clinical update adds fresh context to a stock that has seen a very large 1 year return and a 20.6% gain year to date. Shares...